Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by FactFinder1994on Jul 25, 2021 1:05am
304 Views
Post# 33601631

Get intimate with the details for perspective.

Get intimate with the details for perspective. The RALI-Dx panel test that must now be submitted through a regular FDA process rather than through an EUA, while unfortunate, is just that.  

Re-visit page 7 of the Investor Presentation for at least some prudent perspective.  
Of the $3.7 BILLION+ annual revenue available to SQI based strickly on the few products mentioned in the company document, the delayed RALI-Dx panel represents less than one half of one percent.  In other words greater than 99.5% of the revenue opportunity as stated in the investor presentation remains.  And even the last half percent is simply delayed, not gone.
Also keep in mind that many of SQI's other assets in development that are more than a year away before revenue can be generated, are therefore not yet included in the tally either.

Take a moment to absorb all of that.  Multi-billion dollar opportunity with many shots on goal and a very high probability of success for each, yet the market cap remains below $100M.  Only possible when the story has not been shared, and manipulative forces are at work.      

Further Perspective...

80% of the company is owned by Insiders. (Very bright individuals, under the radar types for the most part that are collectively worth Billions)
 
10% of the company is held by a handful of intimate knowledgeable groups.  (Check out Eden Rahim of Next Edge Capital, for example) 

Retail Holders represent a few percent of the float collectively here at SQI....(this group is viewed as vulnerable, and the next group below are after their small number of shares, as the remainder of the float is unavailable to them).
     
Opportunistic Manipulators make up the remaining few percent of the float, (the wet kindling) that sets the value of the company, (it is easy when there is practically no volume like SQI has) and is most often supported on bullboards such as this with some characters that become all too obvious over time.  They aim to frustrate/mislead those that aren't as intimate with the story/opportunity/details.     

90% of the SQI float is well educated regarding the value opportunity over time and those shares are not available to the manipulators....The 90% know the company will ultimately be worth 10 figures.  The remaining paper is therefore very valuable, and is all the motive needed.       

These manipulative activities have become all too common in Canada.  Some companies are propped up and others are diminished in order to create opportunity for the bad apples. The manipulators may infact be making themselves valnerable, as the activities have become evident to many.       

The moment SQI shares its story, its game over for the manipulators.  With marketing, knowledge, a wide bredth of holders and much higher volume of trading it becomes a stock with a value of integrity that cannot be so easily steered by a few.    

Remember, as few as three incredibly successful insiders own over 75% of the company collectively.  Each having invested north of $20M in SQI.  That leaves very little of the pie to go around.

Can you imagine if the company actually shared its story??  Hundreds of millions of dollars would be looking to get a piece of the action, yet there would be so little available below a buck or two.  Insiders and others with knowledge understand this will soon be valued in dollars, not dimes.  Those that don't fully grasp the opportunity will be vulnerable to manipulators. 

Value Integrity will prevail - stay tuned and be as informed as you can.

Get to know the SQI Covid-19 Antibody test and why it is so valuable.
Also digest the opportunity with regards to Lung/Organ scoring on page 8 & 9 of the Investor Deck.  
Each individual component of SQI is worth many multpiles of todays value.  Collectively it is almost beyond comprehension.  
    
SQI Investor Presentation
<< Previous
Bullboard Posts
Next >>